AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,353,944 | +61.5% | 46,539 | +22.2% | 0.00% | 0.0% |
| Q2 2023 | $1,457,323 | 0.0% | 38,090 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,457,323 | -26.1% | 38,090 | +5.9% | 0.00% | 0.0% |
| Q4 2022 | $1,971,102 | -99.8% | 35,969 | +46.2% | 0.00% | – |
| Q3 2022 | $837,937,000 | +161.8% | 24,609 | -27.3% | 0.00% | – |
| Q2 2022 | $320,090,000 | +21.0% | 33,872 | +81.7% | 0.00% | – |
| Q1 2022 | $264,502,000 | +24.9% | 18,640 | +155.3% | 0.00% | – |
| Q1 2021 | $211,773,000 | -2.3% | 7,300 | -13.1% | 0.00% | – |
| Q4 2020 | $216,720,000 | -16.2% | 8,400 | 0.0% | 0.00% | – |
| Q3 2020 | $258,636,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 1,621,829 | $75,723,196 | 32.88% |
| COMMODORE CAPITAL LP | 1,675,000 | $78,205,750 | 8.79% |
| Ghost Tree Capital, LLC | 360,000 | $16,808,400 | 5.55% |
| Boxer Capital, LLC | 1,676,733 | $78,287 | 3.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 241,357 | $11,268,958 | 3.49% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $27,745,579 | 3.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236,500 | $11,039,820 | 3.42% |
| Logos Global Management LP | 520,000 | $24,278,800 | 3.30% |
| Redmile Group, LLC | 1,811,672 | $84,586,966 | 3.25% |
| Yiheng Capital Management, L.P. | 1,201,591 | $56,102,284 | 3.03% |